What is the recommended anesthetic technique and management for a patient with extrahepatic portal venous obstruction undergoing a meso‑Rex shunt?

Anesthetic Management for EHPVO Meso-Rex Shunt

For patients with extrahepatic portal venous obstruction undergoing meso-Rex shunt, use general anesthesia with volatile agents (isoflurane, sevoflurane, or desflurane), avoid neuraxial blocks, maintain mean arterial pressure >65 mmHg to preserve hepatic perfusion, and use short-acting opioids like fentanyl with atracurium or cisatracurium for neuromuscular blockade 1.

Anesthetic Technique Selection

General Anesthesia is Mandatory

• Regional/neuraxial anesthesia is contraindicated in these patients due to portal hypertension-related coagulopathy and thrombocytopenia, which significantly increase hematoma risk 1
• The guideline explicitly states nerve blocks should be avoided in patients with advanced liver disease due to bleeding complications 1

Induction and Maintenance Agents

Volatile anesthetics are preferred over propofol for maintenance:

• Use isoflurane, sevoflurane, or desflurane as they have minimal hepatic metabolism 1
• Propofol can be used for induction as it shows no significant pharmacokinetic alterations, but volatile agents are superior for maintenance 1
• Ketamine may be considered for induction given its vasoconstrictor effects on systemic circulation with minimal splanchnic impact 1

Critical Hemodynamic Management

Preserve Hepatic Blood Flow

• Maintain mean arterial pressure >65 mmHg throughout the procedure 1
• Hepatic blood flow decreases 35-42% within the first 30 minutes of anesthesia induction 1
• In EHPVO patients, compensatory hepatic artery mechanisms are already compromised, making perfusion pressure maintenance critical 1

Fluid Management Strategy

• Use balanced electrolyte solutions over 0.9% sodium chloride to prevent hyperchloremic acidosis 1
• Avoid hydroxyethyl starch (HES) 130/0.4 - associated with acute kidney injury 1
• Albumin may offer advantages over crystalloids for volume replacement 1
• Avoid sustained hypervolemia in patients showing no fluid responsiveness or volume overload signs 1

Pharmacologic Considerations

Opioid Selection

• Fentanyl is the safest choice - no toxic metabolites and typically requires no dose adjustment 1
• Avoid long-acting opioids like morphine due to delayed elimination 1
• Tramadol can be used cautiously at lower doses with longer intervals 1

Neuromuscular Blockade

• Use atracurium or cisatracurium - they do not rely on hepatic excretion 1
• Monitor neuromuscular blockade throughout the procedure 1
• Sugammadex can rapidly reverse rocuronium-induced blockade if used 1

Drugs to Avoid

• Benzodiazepines in patients with any hepatic encephalopathy 1
• Long-acting opioids (morphine) 1
• High chloride-content colloids 1

Monitoring Requirements

Standard Monitoring Plus:

• Consider arterial line for continuous blood pressure monitoring - note discrepancy between peripheral and central arterial pressures may exist 1
• Trans-esophageal echocardiography is safe even with esophageal varices and useful for hemodynamic instability 1
• Bispectral index monitoring helps guide anesthesia depth, especially important as anesthetic doses are often overestimated in these patients 1
• Pulse contour analysis for cardiac output becomes less reliable as liver disease progresses 1

Electrolyte Management

• Carefully monitor and correct electrolytes, particularly sodium 1
• Avoid rapid correction of hyponatremia to prevent neurological complications 1
• Monitor total daily ion intake in administered fluids 1

Procedure-Specific Context

The meso-Rex bypass is the favored surgical management for pediatric EHPVO with portal hypertension complications but preserved liver function, as it restores physiological hepatopetal portal flow 2, 3. The procedure achieves 87% shunt patency with only 0.3% mortality 4. However, these patients present with thrombocytopenia, splenomegaly, and coagulopathy from portal hypertension 4, making the anesthetic management particularly challenging.

Common Pitfalls to Avoid

• Do not place epidurals or nerve blocks - the bleeding risk from thrombocytopenia and coagulopathy outweighs any benefit 1
• Do not allow hypotension during induction - the first 30 minutes are critical for hepatic perfusion 1
• Do not use standard drug dosing - hepatic dysfunction prolongs elimination half-lives requiring dose reduction and increased intervals 1
• Do not rapidly correct hyponatremia perioperatively 1